23andMe

Discover what 125+ personalized reports have to say about your ancestry, health, traits and more.


Founded
2006
Headcount
399
Open roles
0
Last raised
IPO

SECTION I · THE BRIEF

Inside 23andMe

Brief #58846Updated 18 NOV 2025MOUNTAIN VIEWHEALTHCAREIPO
Employbl Dossier

23andMe

Discover what 125+ personalized reports have to say about your ancestry, health, traits and more.

Founded
2006
Headcount
399
Open roles
0
Last raised
IPO
Section II · Premium ProfileMembers only
  • 01Engineering interview process at 23andMeLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked

7-day free trial · $25/mo · cancel anytime


LEADERSHIP

Founders & key people

Linda AveyLinda Avey
Anne WojcickiAnne Wojcicki
Paul CusenzaPaul Cusenza

OPEN ROLES

Hiring at 23andMe

No open roles listed right now. Check back soon or search all jobs →


FUNDING

Capital raised

Total Amount Raised: $1,118,573,568

23andMe's Investors

23andMe Funding Rounds

  • IPO

    Unknown

  • IPO

    Unknown

  • Post Ipo Equity

    $250,000,000

  • Post Ipo Equity

    $250,000,000

    Post Ipo Equity Investors

    Casdin Capital
    Fidelity
    Foresite Capital
    Anne Wojcicki
    Altimeter Capital
    Richard Branson
  • Series F

    $82,500,000

  • Series F

    $82,500,000

    Series F Investors

    NewView Capital Management
    Sequoia Capital
    Pegasus Tech Ventures
  • Series F

    $300,000,000

  • Series F

    $300,000,000

    Series F Investors

    GSK
    Rancilio Cube
  • Series F

    $250,000,000

  • Series F

    $250,000,000

    Series F Investors

    Sequoia Capital
    Fidelity
    Euclidean Capital
    Altimeter Capital
    Wallenberg Foundations
    Casdin Capital
    G Squared
    Nimble Ventures
    Decacorn
  • Grant

    $1,700,000

  • Grant

    $1,700,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series E

    $115,000,000

  • Series E

    $115,000,000

    Series E Investors

    Fidelity
    WuXi Healthcare Ventures
    Casdin Capital
    Xfund
    NEA - New Enterprise Associates
    MPM Capital
    GV
    EquityZen
    Illumina Ventures
    Lauder Partners
  • Grant

    $1,400,000

  • Grant

    $1,400,000

    Grant Investors

    National Institutes of Health (NIH)
  • Series D

    $50,000,000

  • Series D

    $50,000,000

    Series D Investors

    GV
    Anne Wojcicki
    Sergey Brin
    NEA - New Enterprise Associates
    MPM Capital
    Yuri Milner
  • Series C

    $9,000,000

  • Series C

    $9,000,000

    Series C Investors

    Johnson & Johnson Development
    MPM Capital
  • Series C

    $22,220,289

  • Series C

    $22,220,289

    Series C Investors

    Johnson & Johnson Development
    GV
    NEA - New Enterprise Associates
  • Series B

    $14,200,000

  • Series B

    $14,200,000

  • Series B

    $13,600,000

  • Series B

    $13,600,000

    Series B Investors

    Google
    Sergey Brin
    NEA - New Enterprise Associates
  • Series A

    $8,953,320

  • Series A

    $8,953,320

    Series A Investors

    Google
    NEA - New Enterprise Associates
    Mohr Davidow Ventures
    Genentech
    Stephens Investment Management
    Wendi Deng Murdoch
Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections 23andMe is a part of. Click on the collection name to view similar companies.


LOCATIONS

Where they work

23andMe Headquarters Location

899 W Evelyn Av, Mountain View, CA, 94041-1225

Loading map…